Text Size:SmallerNormalLargerPrint PageE-mail Page


Maternal Opiod Medical Stabilization with an image of a pregnant woman embracing a heart

MOMS


A Foundation for Recovery for both Mother and Baby

The MOMS program is composed of a highly skilled and caring team with resources to help expectant women overcome opioid use disorder and have a good start at becoming successful mothers.

Why it's important for your baby that you receive treatment

Every 25 minutes a baby withdrawing from an opioid is born in the United States, according to the National Institute on Drug Abuse. The number of babies born exposed to drugs and alcohol in the U. S. has increased dramatically over the last ten years. Opioid withdrawal in a newborn causes a condition called Neonatal Abstinence Syndrome (NAS). Babies who are born with NAS may suffer from a lifetime of health issues. Once you have completed your inpatient stay, you will be assisted by our discharge coordinator to create a plan for continuation of treatment that meets the needs of you and your unborn baby.

It may not be easy, but having a healthy baby will be worth it

Any expectant mother suffering from opioid use disorder may be considered for admission into the MOMS program. An assessment will be conducted by our trained and compassionate intake coordinator. Once admitted, patients will be cared for in a respectful and dignified manner. Patients may rest easy assured they are under the 24-hour supervision of caring and specially trained medical professionals. The typical length of stay in the MOMS program is two to seven days. When you are ready to be discharged you will be provided with an individualized treatment plan and any community support services you may need.

Let us help you increase your chances of delivering a healthy baby

During your stay at Twin Lakes our trained physicians will initiate a medication assisted treatment for opioid use disorder. Patients will be treated with a medication called buprenorphine. Studies show that compared to untreated pregnant women, women treated with buprehnorphine had infants with lower risk of a condition called Neonatal Abstinence Syndrome. Other benefits also include shorter treatment time, higher gestational age, weight, and head circumference at birth.

Take the first step

If you or a loved one are ready to seek help, please call today. A respectful and professional admissions specialist (a young mom herself) will talk with you about your situation and answer any questions you may have. There is no greater gift you can give your baby than a healthier start at life!

270-200-4477
embryj@tlrmc.com